Aspargo Labs, Inc., is focused on converting the world’s most meaningful medications into liquid oral suspensions delivered via a proprietary, digitally connected device. Aspargo Labs’ suspension technology offers several key advantages, including improved absorption, ease of administration, flexible dosing, and improved patient adherence. Aspargo is leveraging its unique technology platform to transform a wide range of medications across various therapeutic areas. The initial focus is a liquid oral sildenafil suspension currently marketed by Aspargo in multiple countries.
Company Details
- Employees
- 39
- Founded
- -
- Address
- New York, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://aspargolabs.com/
- Keywords
- Sirona Medical Technologies.
- HQ
- New York
Aspargo Laboratories, Inc. Questions
Aspargo Laboratories, Inc.'s website is https://aspargolabs.com/
Aspargo Laboratories, Inc.'s LinkedIn profile is https://www.linkedin.com/company/aspargo-laboratories-inc
Aspargo Laboratories, Inc. has
39 employees.
View email and phone details for 39
employees at Aspargo Laboratories, Inc..
Aspargo Laboratories, Inc.'s industry is
Biotechnology Research
Aspargo Laboratories, Inc.'s top competitors are
Inizio Engage,
Synergy Research,
Gsk,
Abbvie,
Ipg Health,
I+med,
Madrigal Pharmaceuticals,
Daiichi Sankyo Deutschland Gmbh,
Sirona Medical Technologies, Inc.,
Aspargo.
Aspargo Laboratories, Inc.'s categories are Biotechnology Research
Aspargo Laboratories, Inc.'s founding year is 2020
